Petitprez and co-workers [19] showed recently that a high density of CD8+ cells plus PD-L1+ cells was associated with higher risk of biochemical recurrence in lymph node-positive patients, but no association was found with CD20+ cells. This evidence concerns the gene CD8A and benign neoplasm.